The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1973, 111: 1554-1563.
Copyright © 1973 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamaoka, T.
Right arrow Articles by Katz, D. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hamaoka, T.
Right arrow Articles by Katz, D. H.

Cellular Site of Action of Various Adjuvants in Antibody Responses to Hapten-Carrier Conjugates1

Toshiyuki Hamaoka and David H. Katz2

From the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Abstract

The adjuvant action of concanavalin A (Con A), Escherichia coli lipopolysaccharide (LPS), beryllium sulphate (Be salt) and Bordetella pertussis vaccine have been analyzed in a system measuring humoral immune responses to hapten-carrier conjugates in mice. For the definition of the cellular locus of their action, the effect of these adjuvants on adoptive secondary anti-hapten antibody responses was studied. Spleen cells from 2,4-dinitrophenyl (DNP)-keyhole limpet hemocyanin (KLH) primed donors, which normally fail to develop adoptive secondary anti-DNP responses to a heterologous conjugate such as DNP-bovine {gamma}-globulin (BGG), can be stimulated to do so when an appropriate dose of adjuvant is administered with DNP-BGG. The capacity for the adjuvants employed to exert this effect requires the presence of thymus-derived (T) lymphocytes, since depletion of such cells by treatment of the donor cell inoculum with anti-{theta} serum and complement in vitro before adoptive transfer abrogates the response to DNP-BGG plus adjuvant. Moreover, evidence is presented which demonstrates that these substances exert their adjuvant action through the small number of unimmunized BGG-specific T lymphocytes in the donor cell inoculum. This conclusion derives from the failure of adjuvants to augment adoptive secondary anti-DNP responses to the DNP derivative of a non-immunogenic copolymer of d-glutamic acid and d-lysine for which there are few or no specific, functional T cells.

Footnotes

1 This investigation was supported by Grant AI-10630 from the National Institutes of Health, United States Public Health Service.

2 To whom reprint requests should be sent.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.